X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
respiratory system (234) 234
humans (220) 220
index medicus (182) 182
male (151) 151
female (144) 144
middle aged (132) 132
aged (112) 112
critical care medicine (96) 96
copd (94) 94
obstructive pulmonary-disease (91) 91
chronic obstructive pulmonary disease (89) 89
emphysema (84) 84
abridged index medicus (64) 64
pulmonary disease, chronic obstructive - physiopathology (56) 56
lung diseases, obstructive (55) 55
quality of life (51) 51
mortality (45) 45
treatment outcome (43) 43
adult (42) 42
respiratory tract diseases (41) 41
lung diseases (40) 40
care and treatment (38) 38
risk factors (38) 38
research (36) 36
severity of illness index (33) 33
analysis (32) 32
disease progression (31) 31
forced expiratory volume (31) 31
respiratory function tests (30) 30
surgery (30) 30
pulmonary emphysema - surgery (29) 29
spirometry (29) 29
pulmonary disease, chronic obstructive - diagnosis (28) 28
pulmonary emphysema - physiopathology (28) 28
smoking (28) 28
pulmonary disease, chronic obstructive - drug therapy (27) 27
follow-up studies (26) 26
lungs (26) 26
patients (26) 26
inflammation (25) 25
lung-function (25) 25
cardiac & cardiovascular systems (24) 24
diagnosis (24) 24
lung - physiopathology (24) 24
obstructive lung disease (24) 24
pneumonectomy (24) 24
medicine, general & internal (23) 23
pulmonary disease, chronic obstructive - therapy (23) 23
air-flow obstruction (22) 22
usage (22) 22
asthma (21) 21
dyspnea (21) 21
smokers (21) 21
article (20) 20
pneumonectomy - methods (20) 20
prospective studies (20) 20
pulmonary disease, chronic obstructive - genetics (20) 20
time factors (20) 20
clinical trials (19) 19
disease (19) 19
patient outcomes (19) 19
quality-of-life (19) 19
studies (19) 19
emphysema, pulmonary (18) 18
epidemiology (18) 18
original research (18) 18
prevention (18) 18
pulmonary disease, chronic obstructive - complications (18) 18
retrospective studies (18) 18
lung volume reduction surgery (17) 17
management (17) 17
united states (17) 17
volume-reduction surgery (17) 17
aged, 80 and over (16) 16
cohort studies (16) 16
health aspects (16) 16
tomography, x-ray computed (16) 16
exercise (15) 15
hospitalization (15) 15
phenotype (15) 15
pulmonary and respiratory medicine (15) 15
pulmonary disease, chronic obstructive - epidemiology (15) 15
bronchoscopy (14) 14
exacerbation (14) 14
exacerbations (14) 14
exercise tolerance (14) 14
hyperinflation (14) 14
lung - diagnostic imaging (14) 14
pulmonary/respiratory (14) 14
smoking - adverse effects (14) 14
surveys and questionnaires (14) 14
chronic bronchitis (13) 13
comorbidity (13) 13
double-blind (13) 13
forced expiratory volume - physiology (13) 13
randomized controlled-trial (13) 13
randomized-trial (13) 13
risk (13) 13
therapy (13) 13
transplantation (13) 13
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


American Journal of Respiratory and Critical Care Medicine, ISSN 1073-449X, 02/2013, Volume 187, Issue 3, pp. 228 - 237
Journal Article
Chest, ISSN 0012-3692, 11/2016, Volume 150, Issue 5, pp. 995 - 997
Journal Article
The European respiratory journal, ISSN 0903-1936, 2018, Volume 51, Issue 2, pp. 1702712 - 1702712
Chronic obstructive pulmonary disease (COPD) is a major worldwide cause of death, and a leading cause of chronic disability and driver of high healthcare... 
MEDICINE | RESPIRATORY SYSTEM | Humans | Pulmonary Disease, Chronic Obstructive | Lung diseases | Chronic obstructive pulmonary disease | Obstructive lung disease
Journal Article
International Journal of COPD, ISSN 1176-9106, 08/2017, Volume 12, pp. 2307 - 2312
Long-acting bronchodilators are the mainstay of the treatment of COPD. With the advent of several combination inhalers with long-acting antimuscarinic agents... 
Adverse events | Formoterol fumarate | Long-acting beta agonist | Exacerbations | Inhaled corticosteroids | Metered-dose inhaler | Glycopyrronium | Long-acting antimuscarinic agent | LONG-ACTING BETA2-AGONISTS | EFFICACY | SAFETY | GLYCOPYRROLATE | NVA237 | adverse events | metered-dose-inhaler | DRY POWDER | INHALED FORMOTEROL | TRIAL | OBSTRUCTIVE PULMONARY-DISEASE | formoterol fumarate | RESPIRATORY SYSTEM | exacerbations | long-acting antimuscarinic agent | glycopyrronium | long-acting beta agonist | WITHDRAWAL | inhaled corticosteroids | Glycopyrrolate - adverse effects | Pulmonary Disease, Chronic Obstructive - diagnosis | Bronchodilator Agents - administration & dosage | Humans | Muscarinic Antagonists - adverse effects | Formoterol Fumarate - adverse effects | Administration, Inhalation | Treatment Outcome | Lung - physiopathology | Pulmonary Disease, Chronic Obstructive - physiopathology | Disease Progression | Forced Expiratory Volume | Muscarinic Antagonists - administration & dosage | Time Factors | Adrenergic beta-2 Receptor Agonists - adverse effects | Glycopyrrolate - administration & dosage | Lung - drug effects | Metered Dose Inhalers | Adrenergic beta-2 Receptor Agonists - administration & dosage | Bronchodilator Agents - adverse effects | Drug Combinations | Formoterol Fumarate - administration & dosage | Pulmonary Disease, Chronic Obstructive - drug therapy | Lung diseases, Obstructive | Usage | Drug therapy, Combination | Drug therapy | Risk factors | long acting antimuscarinic agent | Formoterol Fumarate | long acting beta agonist | Metered Dose Inhaler | COPD
Journal Article
The American Journal of Medicine, ISSN 0002-9343, 09/2018, Volume 131, Issue 9, pp. 23 - 29
Chronic obstructive pulmonary disease (COPD) frequently exists alongside other chronic diseases. Comorbidities can have a significant influence on the course... 
Comorbidities | COPD | DEPRESSION | INHALED CORTICOSTEROIDS | SLEEP-APNEA | NONSELECTIVE BETA-BLOCKERS | PREVALENCE | SALMETEROL-FLUTICASONE | MEDICINE, GENERAL & INTERNAL | HEART-DISEASE | DOUBLE-BLIND | COPD PATIENTS | HEALTH-STATUS
Journal Article
The New England Journal of Medicine, ISSN 0028-4793, 05/2018, Volume 378, Issue 18, pp. 1671 - 1680
The frequency of COPD exacerbations during treatment with a triple inhaler — delivering a long-acting beta-agonist (LABA), a long-acting muscarinic antagonist... 
MEDICINE, GENERAL & INTERNAL | OBSTRUCTIVE PULMONARY-DISEASE | IMPACT | PARALLEL-GROUP | DOUBLE-BLIND | TIOTROPIUM | RANDOMIZED CONTROLLED-TRIAL | FLUTICASONE PROPIONATE/SALMETEROL | SALMETEROL | Glucocorticoids - administration & dosage | Bronchodilator Agents - administration & dosage | Humans | Middle Aged | Muscarinic Antagonists - adverse effects | Benzyl Alcohols - administration & dosage | Hospitalization - statistics & numerical data | Male | Dyspnea - etiology | Quinuclidines - administration & dosage | Chlorobenzenes - administration & dosage | Adrenergic beta-Agonists - administration & dosage | Adult | Female | Bronchodilator Agents - adverse effects | Adrenergic beta-Agonists - adverse effects | Glucocorticoids - adverse effects | Double-Blind Method | Drug Administration Schedule | Administration, Inhalation | Pulmonary Disease, Chronic Obstructive - complications | Muscarinic Antagonists - administration & dosage | Androstadienes - administration & dosage | Intention to Treat Analysis | Quality of Life | Dyspnea - drug therapy | Aged | Drug Combinations | Pulmonary Disease, Chronic Obstructive - drug therapy | Treatment outcome | Lung diseases, Obstructive | Care and treatment | Usage | Analysis | Diagnosis | Inhalers | Pneumonia | Acetylcholine receptors (muscarinic) | Glucocorticoids | Lung diseases | Critical care | Fluticasone | Patients | Quality of life | Medicine | Hospitals | Obstructive lung disease | Population | Chronic obstructive pulmonary disease | Drug dosages | Life Sciences | Human health and pathology | Pulmonology and respiratory tract
Journal Article
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, ISSN 1073-449X, 02/2020, Volume 201, Issue 3, pp. 391 - 392
Journal Article
The New England Journal of Medicine, ISSN 0028-4793, 09/2010, Volume 363, Issue 13, pp. 1233 - 1244
Journal Article
The New England Journal of Medicine, ISSN 0028-4793, 10/2017, Volume 377, Issue 17, pp. 1613 - 1629
Journal Article
The European respiratory journal, ISSN 0903-1936, 03/2017, Volume 49, Issue 3, pp. 1700214 - 1700214
Journal Article
JAMA - Journal of the American Medical Association, ISSN 0098-7484, 10/2018, Volume 320, Issue 15, pp. 1541 - 1542
Journal Article
Journal Article
Medical Clinics of North America, ISSN 0025-7125, 2019, Volume 103, Issue 3, pp. 453 - 453
Chronic obstructive pulmonary disease (COPD) is a leading cause of death nationally and worldwide. Cigarette smoking is the most common risk factor in the... 
Acute exacerbation | Emphysema | Chronic bronchitis | COPD | GLOBAL BURDEN | SMOKING-CESSATION | RISK-FACTORS | LUNG-FUNCTION | MEDICINE, GENERAL & INTERNAL | THERAPY | EXACERBATIONS | GLYCOPYRRONIUM | ROFLUMILAST | RESPIRATORY-FAILURE
Journal Article
Thorax, ISSN 0040-6376, 12/2017, Volume 72, Issue Suppl 3, p. A231
Results from FULFIL have shown statistically significant improvements in lung function and health-related quality of life, and a reduction in exacerbation... 
Confidence intervals | Chronic obstructive pulmonary disease
Journal Article
The New England Journal of Medicine, ISSN 0028-4793, 10/2016, Volume 375, Issue 17, pp. 1617 - 1627
Journal Article